Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients

N/ATerminatedNCT02416414

QIAGEN Gaithersburg, Inc166 enrolled

Overview

To compare the performance of the QuantiFERON Monitor assay against existing methodology.

Study Type

OBSERVATIONAL

Enrollment

166

Conditions

Cell-mediated Immune Response

Interventions

QuantiFERON Monitor AssayDEVICE

Assay to measure cell-mediated immune function using QuantiFERON Monitor assay.

Existing methodologyDEVICE

Assay to measure cell-mediated immune function using existing methodology.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Solid Organ Transplant Recipient Inclusion Criteria: * Provide Informed Consent * Received a solid organ transplant Exclusion Criteria: * Pregnancy or recent lactation (\<1yr) * Treatment of Rejection Healthy Control Inclusion Criteria: * Provide Informed Consent Exclusion Criteria: * Currently taking any immunomodulatory medication * A history of immunosuppressive disease or immunosuppression condition or history of autoimmune diseases * Current pregnancy or recent lactation (\<1yr) * Currently taking antiviral medication * Currently being treated for infectious diseases

Locations (4)

University of California Los Angeles

Los Angeles, California, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

The Cleveland Clinic Foundation

Cleveland, Ohio, United States

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

Outcomes

Primary Outcomes

Cell-mediated immune response.

Time frame: 1 day (At time of enrollment)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.